Category Archives for "Press Releases"

0 Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China

The Global Stem Cells Group has established a collaborative alliance with HANK Bioengineering Co., Ltd. of Shenzhen, China.

Global Stem Cells Group.com has announced a newly formed alliance with Shenzhen HANK Bioengineering Co., Ltd. and its Chinese-American founder Mingjie Zhang, M.D., Ph.D. The alliance will establish a stem cells training course in the City of Shenzen, Guangdong Province, China in September 2015.

Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration from 1995 to 2013 in various research positions including National Research Center (NRC) senior associate from 1995 to 1997. In 2012 he earned the Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.

In 2013, Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.

Shenzhen HANK is also a biotechnology service provider committed to the development and application of multiple immune cell therapy systems. The company has up to 20 cell therapy products of 4 series approved by the CFDA, including lymphocyte culture medium (NK, CTL and Treg cell in vitro culture reagents), lymphocyte serum-free culture medium, lymphocyte separation media, and lymphocyte freezing medium.

“Dr. Zhang and HANK Bioengineering will work seamlessly with our research, product development and education programs,” says Benito Novas, Global Stem Cells Group CEO. “This is a great opportunity for us to expand into China and work with one of the world’s most accomplished cell therapy researchers in his certified, cutting-edge cell biology laboratories.”

0 Mario Camacho Alcocer Joins Global Stem Cells Group Faculty

The Global Stem Cells Group has announced the addition of Biomedical Researcher Mario Camacho Alcocer to its faculty.

GlobalStemCellsGroup.com has recruited Mario Camacho Alcocer to the company’s growing faculty. Camacho Alcocer, a biomedical researcher and founding partner of Criogenix SA de CV in Queretaro, Mexico, will join GSCG’s team of biomedical professors who will teach the “Diplomat in Cell Therapy and Tissue Engineering” program.

Criogenix SA de CV is a private company registered in the National Record of Scientific and Technological Institutions and Companies in Mexico (RENIECYT).
Camacho Alcocer will teach two-day, interactive training courses on adult stem cell extraction and re-integration to physicians and qualified medical practitioners who wish to learn and use the process in their practices.

Camacho Alcocer is accomplished in generating and applying new stem cell therapeutic protocols and technologies. His current research focuses on extracellular matrix interactions to regulate the dynamic of defined stem cells populations, with a goal to regenerate functional capabilities of specific tissues (or to develop tissues in vitro), as well as the development of specific scaffolds for cell culture. His research is central to Criogenix SA de CV’s development of a major integral stem cell unit management system for therapeutic applications.

Global Stem Cells Group and StemCell Center are expanding the company’s clinical presence worldwide by partnering with experienced and qualified regenerative medicine physicians to open new clinics licensed and developed under the Cellgenic banner.

In 2014, Global Stem Cells Group expanded its StemCell Center’s global presence to 20 countries. Cellgenic offers stem cell treatments to help treat a variety of diseases and conditions including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, and pain due to injuries at various facilities worldwide.

Cellgenic is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. Cellgenic clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.

The Global Stem Cells Group is committed to the highest standards in service and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.

0 Global Stem Cells Group, Inc. Announces Launch of New Stem Cell Harvesting Products

Global Stem Cells Group and Cellgenic announce the launch of two new kits for physicians to use in isolating and harvesting stem cells from bone marrow and adipose tissue based on Adistem technology.

In answer to industry-wide requests for more accessible solutions to stem cell procedures, Global Stem Cells Group, Inc. and Cellgenic have announced the launch of two new stem cell harvesting and isolation kits.

The Cellgenic BMAC 60 mL concentrating system is a high performing concentrating system for bone marrow aspirate. This kit come complete with a bone marrow filter, a bone marrow aspirating needle and a locking syringe to help maintain suction during the aspirating process. The BMAC 60 kit includes bone marrow concentrate up to 11 times the baseline values, to produce 6-8 mL BMC from a 60 mL sample of bone marrow aspirate.

The Cellgenic 60 mL Adipose Derived Stem Cell (ADSC) Kit System includes all the tools and consumables for the extraction of adipose-derived stem cells from 60 mL of lipoaspirated fat. The ADSC kit is currently being used in clinical procedures for lung disease, intra-articular injections for osteoarthritis of the knee and hip, cosmetic surgery and acne scarring, dermal injections, stem cell enriched fat transfer, wounds, chronic ulcers and other chronic conditions. The enzymatic component used to obtain the stromal vascular fraction (SVF) is provided by Adistem.

The Cellgenic ADSC Kit System is available in three versions:
Gold, to conduct in-office stem cell procedures with certified GMP components for reliable performance.

Platinum, with all the benefits of the basic (gold) kit plus a sterilized PRP close system with vortex engineering method to minimize platelet loss. One set of individually packed Tulip Gems instruments are added for safe and precise adipose tissue extraction.

Titanium, the perfect state-of-the-art deluxe kit system used by a growing number of regenerative medicine physicians and recognized as the perfect preparation for virtually all clinical applications. Built with Emcyte technology, the Cellgenic Titanium kit has been independently reviewed and proven in various critical performance points that make a difference in patient outcomes.

The Titanium kit is currently being used in topical procedures such as intra-articular injection for osteoarthritis of the knee and hip, cosmetic surgery and acne scarring, dermal injection, stem cell enriched fat transfer, wounds chronic ulcers among other chronic conditions.
According to Global Stem Cells Group CEO Benito Novas, the entire Global Stem Cells Group faculty and scientific advisory board worked together to develop the kits.

“These new products will help us carry out our mission to provide accessible GMP certified kits to our member client, ensuring that more patients will be able to gain access to these therapies,” says Novas. “We are confident that the regenerative medicine industry will be excited to receive these products.”

About Adistem:
AdiStem Ltd. is a provider of photo-activation technology and medical solutions that assist in orthopedic, cosmetic, neurologic, pulmonary, metabolic and plastic/reconstructive surgery procedures.

The company owns proprietary technology for PRP procedures and for autologous adult adipose-derived stem cell isolation and administration. The use of AdiLight-2 for the photo activation of PRP requires no training. On the other hand, the adult stem cell technology is shared with qualified clinicians through instructional courses, workshops and seminars.

AdiStem has also isolated specific biomolecules from autologous adult adipose-derived stem cells that target a number of chronic diseases including HIV/Aids, pain, and Type II diabetes.

0 Global Stem Cells Group Announces Alliance with Regenerative Technology

Global Stem Cells Group announced that it has signed a memorandum of understanding with the Regenerative Technology Alliance (RTA) to evaluate and promote stem cell training programs.

Global Stem Cells Group and the Regenerative Technology Alliance (RTA) have signed a memorandum of understanding to evaluate and promote stem cell training programs. RTA, a global provider of standards and certification for the emerging fields of regenerative medicine and science, will work with the Global Stem Cells Group to evaluate the regenerative medicine company’s training programs and assess GSCG’s participating physicians against the RTA’s established international standards for the practice of regenerative and cell-based medicine.

“Our new alliance with the RTA is a natural step toward establishing GSCG’s recognition as a global leader in stem cell medicine,” says Global Stem Cells Group CEO Benito Novas. “This is a perfect fit for us, as Global Stem Cells Group shares the RTA’s focus on high standards and transparency, especially when it comes to patient safety and advancing the field of stem cell medicine.”

“We are very pleased to have this alliance,” says David Audley, General Secretary and Chair of the RTA. “Our goal is to provide the highest level of transparency and oversight for the industry. Working with Global will allow us to have a direct and dramatic impact on physician training.”

About the RTA
The Regenerative Technology Alliance (RTA) a global provider of standards and certification for the emerging fields of regenerative medicine and science, is a 501(c)3 and is supported by donations from individuals, corporations and foundations to help advance its critical mission of bringing peer oversight and transparency to the field of cell-based and regenerative medicine.

0 Global Stem Cells Group Announces Alliance with Advancells

Global Stem Cells Group has announced an agreement to share protocols with Advancells, a pioneer stem cell company that provides a range of safe treatments for various diseases. The alliance will also pave the way for Global Stem Cells Group to expand operations in India.

Global Stem Cells Group, Inc. announced an alliance with India-based stem cells company Advancells.com, to share protocols and expand GSCG operations in the India subcontinent with stem cell training and a new treatment center.

Advancells, a pioneer stem cell company with some of the most advanced protocols in the world, focuses on therapeutic applications of regenerative medicine primarily used in stem cells generated from the patient’s own body. Advancells delivers technologies for safe and effective treatments using their flagship technologies including autologous stem cell therapy from bone marrow and adipose tissue to patients worldwide; Global Stem Cells Group will implement some Advancells technologies in the StemCell Center of worldwide clinics.

Since 2005, Advancells has safely treated thousands of patients for a range of diseases and medical conditions in its various clinics around the globe. Advancells is supported by physicians, stem cell experts and clinical research scientists to continually monitor and improve the effectiveness of its quality management system with excellence and innovation.

“We are pleased to partner with Global Stem Cells Group, to combine our knowledge and expand our ability to bring stem cell medicine to patients worldwide,” says Advancells CEO Vipul Jain. “I am looking forward to a long and productive alliance.”
For more information, visit the Global Stem Cells Group website, email bnovas(AT)stemcellsgroup.com, or call 305-560-5337.

About Advancells:
Advancells is focused on the therapeutic applications of regenerative medicine primarily used in stem cells generated from the patient’s own body. Using technologies like autologous stem cell therapy from bone marrow and adipose tissue, Advancells has been successfully treating patients on a global level since 2005. The company strives to maintain scientific and ethical traditions through Good Manufacturing Practices in accordance with the accepted national and international norms.

0 Global Stem Cells Group Hands-on Training Course in Barcelona Heading to Additional Euro Cities in 2015

Response to the Global Stem Cells Group’s practical, hands-on stem cells training course in November paves the way to scheduling more courses in major European cities in 2015

After a successful first run in Spain last month, Global Stem Cells Group, has announced the decision to take the biotech company’s hands-on stem cell training course to additional European cities in 2015. GSCG subsidiary Stem Cell Training, Inc. and Dr. J. Victor Garcia conducted the “Adipose Derived Harvesting, Isolation and Re-integration Training Course” for medical professionals in Barcelona Nov. 22-23, 2014.

The two-day, hands-on intensive training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from adipose tissue and bone marrow. The objective of the training is to bridge the gap between bench science in the laboratory and the doctor’s office by teaching effective, in-office regenerative medicine techniques.

Global Stem Cells Group will release a schedule of cities and dates for future training classes in upcoming weeks.

0 Global Stem Cells Group Announces Plans to Hold Four International Symposiums on Stem Cells and Regenerative Medicine in 2015

The Global Stem Cells Group, Inc. has announced plans to host at least three international symposiums on stem cells and regenerative medicine in Latin America, and one in Miami in 2015.

GlobalStemCellsGroup, Inc. has announced plans to host a minimum of four international symposiums on stem cell research in 2015. The symposiums will be held in three Latin American countries—Chile, Mexico and Colombia—in which Global Stem Cells has established state-of-the-art stem cell clinics staffed with expert medical personnel trained in regenerative medicine, through the StemCell Center.

The fourth symposium will be held in Miami.

The decision follows the success of the Global Stem Cells Group’s first International Symposium on Stem Cells and Regenerative Medicine, held Oct. 2, 3 and 4 in Buenos Aires, Argentina. Global Stem Cells Group CEO Benito Novas says the Buenos Aires event, combined with its steady growth of new clinics throughout Latin America, has provided additional motivation to schedule more stem cell symposiums in an effort to further educate the medical community on the latest advancements in stem cell therapies.

Thanks to Global Stem Cells Group’s growing network of world-class stem cell researchers, treatment practitioners and investors committed to advancing stem cell medicine, the company is rapidly moving closer to its goal of helping physicians to bring treatments into their offices for the benefit of patients.
More than 900 physicians, researchers and regenerative medicine experts from around the world attended the Buenos Aires symposium, and Novas expects that number to grow with upcoming conferences.

“We will continue to bring together a variety of committed stem cell advocates from the U.S., Mexico, Greece, Hong Kong and other regions around the globe, to be joined by a team of knowledgeable speakers, each one presenting the future of regenerative medicine in their field of specialty,” Novas says.
Regenerative medicine as a field is still in its infancy, according to Global Stem Cell Group President and CEO Benito Novas.

“Our objective is to [open a dialogue among the world’s medical and scientific communities in order to advance stem cell technologies and translate them into point of care medicine to the best of out abilities,” Novas says. “Our mission is to bring the benefits of stem cell therapies to the physician’s office safely, efficacy and compliance with the highest standards of care with safety, efficacy and complying with the highest standard of care the world has to offer.

The purpose of each symposium is to bring top stem cell scientists together to share their knowledge and expertise in regenerative medicine, and begin the process of separating myths from facts when it comes to stem cell science and technology.

0 Global Stem Cell Group’s Stem Cell Training to Launch Post-graduate Studies Program in Stem Cell Therapies and Regenerative Medicine

Stem Cell Training and Bioheart, Inc. have announced plans to launch a post-graduate studies program in stem cell and regenerative medicine, to be conducted in Miami in 2015.

Stem Cell Training, Inc., a division of Global Stem Cells Group, Inc., has announced plans to launch a post graduate studies program in stem cell therapies and regenerative medicine in 2015.

The program will include five days of intensive, interactive training coursework with classroom instruction and laboratory practice through didactic lectures, hands-on practical experience in laboratory protocols and relevant lessons in regulatory practices.

Global Stem Cells Group Advisory Board member Dr. David B. Harrell, PhD will teach the coursework and perform laboratory instruction, accompanied by a series of guest lecturers from the Global Stem Cells Group faculty of scientists.

Attendees will receive hands-on training in techniques for a variety of laboratory processes, and gain insight into the inner workings of a cGMP laboratory and FDA registered tissue bank. Regenerative medicine experts with more 15 years of experience in the field will train attendees and provide the necessary tools to implement regulatory and clinical guidelines in a cGMP laboratory setting

The graduate course is to be held four times in Miami in 2015.

Course details, objectives and instruction include:
Laboratory Training
Hands-On Training
Plating Stem Cells
Harvesting and Freezing stem cells (perform counts and flow)
Gram Stain
Trypan
Mycoplasma
Gowning to enter cleanroom
Flow Cytometry
Endotoxin
Sterility
Environmental monitoring
Calibration and PM
Didactic Lectures will include:
Stem Cell Biology
Cell Culture
Trypsin
Plating
Flow Cytometry
Gram Stain
Trypan
Potency (differentiation)
Cryopreservation
Quality control: endotoxin, sterility, mycoplasma
Gowning to enter cleanroom
Cleanroom Maintenance
Environmental monitoring
Laboratory Protocols
For additional information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337.

About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

About David B. Harrell, PhD, Brt, OF, FAABRM, FRIPH:
David B. Harrell received his PhD in Molecular Biology, focusing on inter- and intra-cellular communications. Harrell pursued post-doctoral studies at Harvard, Yale, and the University of Rochester and holds national and international awards for his groundbreaking research in signal transduction and cellular communication. Harrell is the owner and chief consultant of Harrell BioScience Consulting, LLC.

Named to Who’s Who in Molecular Biology as well as Public Health and Epidemiology, Harrell is an active reviewer and sits on the editorial boards of several clinical and scientific journals, as well as government agencies. Harrell has several publications in the areas of tissue regeneration, stem cells, neuroscience and epidemiology, and now focuses heavily on translational research. He is a member of the Board of Directors of the American Academy and Board of Regenerative Medicine.

0 Global Stem Cells Group, Inc. to Attend the VI Annual World Congress on Anti-Aging Medicine in Mexico City

Global Stem Cells Group has announced plans to attend the Vl World Congress on Anti-Aging, Regenerative and Aesthetic Medicine in Mexico City, Feb 13, 14 and 15, 2015. Joseph Purita, M.D., head of the Global Stem Cells Group Scientific Advisory Board, will be a keynote speaker.

Joseph Purita, M.D., will represent Global Stem Cells Group, Inc. as a keynote speaker at the VI Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine (A4M) in Mexico City Feb, 13-15, 2015. Purita, who heads the Global Stem Cells Group Scientific Advisory Board, will join other global leaders in the field of anti-aging and regenerative medicine.

Hosted by the American Academy of Anti-aging Medicine (A4M), the conference will be attended by physicians and medical practitioners from different countries and disciplines who will gather to discuss the newest therapies, protocols and innovative procedures available to target health problems associated with old age.

Purita, a pioneer in the use of stem cell therapies in orthopedics, will be joined by Dra Maritza Novas, R.N., M.S.N., a lead trainer and part of the research and development team for Stem Cell Training, Purita and Novas will present the latest advances in evidence-based, best-practice protocols for the early detection, prevention and treatment of medical problems associated with aging.

Global Stem Cells Group plans to host a booth at the conference to present the company’s growing line of regenerative medicine products and services. The event will take place at the Fiesta Americana Reforma Hotel in Mexico City. Attendees will have access to practical and theoretical workshops on a variety of topics related to anti aging medicine, regenerative therapies and cosmetic medicine, and will be able to witness procedures performed by specialists.

Conferences like this one set the standard for medical management and disease treatment for elderly patients.

For more information on the VI Annual World Congress on Anti-Aging Medicine, visit the a4m-mexico website.

0 Global Stem Cells Group and Portal Medestetica to Launch Latin American Stem Cell Portal

The Global Stem Cells Group is joining Argentinian Portal Medestetica to launch Portalstemcells.com to promote education and cutting edge science throughout Spain and Latin America.

GlobalStemCellsGroup.com has announced plans to team with Portal Medestetica, the largest physician portal in Lain America, to launch Portalstemcells.com, a new portal dedicated to providing physicians in Spain and Latin America with relevant information, clinical research news and products relating to stem cells and regenerative medicine.

The new collaboration between Global Stem Cells Group and Portal Medestetica will answer a growing need to expand the reach of high-impact news, studies and breakthroughs, and significantly advance the clinical utilization of stem cell research and clinical trials throughout Latin America. The Portalstemcells.com site is designed to help promote the latest state-of-the-art developments in regenerative medicine as they become available, and to share educational content with physicians throughout the region.

“Portalstemcells.com will be the ideal vehicle to promote education and cutting-edge science throughout the region,” says Ricardo de Cubas, founder of Global Stem Cells Group. “The potential of regenerative medicine and stem cells therapies inspiring the medical community to find real opportunities to repair or replace tissue damaged from disease, relieve pain and provide the potential for curing chronic diseases where no cure existed before.”

The Portalstemcells.com site is aimed at fostering growth and ethical development in the fast-moving field of stem cell medicine by filling a gap in the resources available throughout Latin America. The goal is to elevate the delivery of stem cell science in order to impact the lives of many patients worldwide.